Shots:

• The provincial government is improving the sustainability of its public drug plans by expanding the use of biosimilars
• This initiative follows similar policies implemented by British Columbia and Alberta over the past 2yrs.- where 10-000 of patients in each province were safely switched from an originator biologic drug to a biosimilar
• The initiative allows the government to fund new drugs as switching to biosimilar results in savings. The province’s plans to provide subsidized drug coverage for about 135-000 people while in 2019-20- the province invested about $220M in these drug plans

  Ref: Biosimilars | Image: Twitter